CompletedNot Applicable

Stellate Ganglion Block to Treat Long COVID 19 Case Series

United States41 participantsStarted 2022-09-01

Plain-language summary

An assessment of the effectiveness of Stellate Ganglion Block in alleviating symptoms of Long COVID-19.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: People who scheduled themselves for a SGB in our clinics in Colorado. \- Exclusion Criteria: Stellate Ganglion Block Contraindications \-

What they're measuring

Symptom Response

Timeframe: 3 months

Trial details

NCT IDNCT05812209

SponsorMetamorphosis LTD

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-12-31

View on ClinicalTrials.gov More Long COVID trials